1. Home
  2. HGBL vs ALGS Comparison

HGBL vs ALGS Comparison

Compare HGBL & ALGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Heritage Global Inc.

HGBL

Heritage Global Inc.

HOLD

Current Price

$1.34

Market Cap

46.9M

ML Signal

HOLD

Logo Aligos Therapeutics Inc.

ALGS

Aligos Therapeutics Inc.

HOLD

Current Price

$7.18

Market Cap

49.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HGBL
ALGS
Founded
1937
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
46.9M
49.7M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
HGBL
ALGS
Price
$1.34
$7.18
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$4.00
$46.67
AVG Volume (30 Days)
798.1K
80.9K
Earning Date
03-12-2026
03-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.09
N/A
Revenue
$49,890,000.00
$2,646,000.00
Revenue This Year
$16.03
N/A
Revenue Next Year
$5.33
N/A
P/E Ratio
$15.84
N/A
Revenue Growth
0.02
N/A
52 Week Low
$1.21
$3.76
52 Week High
$2.39
$29.54

Technical Indicators

Market Signals
Indicator
HGBL
ALGS
Relative Strength Index (RSI) N/A N/A
Support Level N/A N/A
Resistance Level N/A N/A
Average True Range (ATR) 0.00 0.00
MACD 0.00 0.00
Stochastic Oscillator 0.00 0.00

Price Performance

Historical Comparison
HGBL
ALGS

About HGBL Heritage Global Inc.

Heritage Global Inc values and monetizes industrial and financial assets by providing acquisition, disposition, valuation, and lending services for surplus and distressed assets. It aids in facilitating the economy by diverting useful industrial assets from landfills and operating a supply chain by overseeing the post-sale account activity of financial assets. The group operates in four segments namely Auction and Liquidation; Refurbishment and Resale; Brokerage and Specialty Lending. It generates maximum revenue from the Auction and Liquidation segment. The Auction and Liquidation segment, through HGP, operates as a full-service auction, appraisal, and asset advisory firm, including the acquisition of turnkey manufacturing facilities and used industrial machinery and equipment.

About ALGS Aligos Therapeutics Inc.

Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.

Share on Social Networks: